Drugs / DTPa-HBV-IPV/Hib vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00320463 | Apr 2006 → Jan 2007 | diphtheria, hepatitis B virus infection, poliomyelitis, tetanus | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTPa-HBV-IPV/Hib vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00320463 ↗ |
| Modality | Vaccine | “DTPa-HBV-IPV/Hib vaccine” NCT00320463 ↗ |